August 2024 FDA Recall Mupirocin by Glenmark Pharmaceuticals Inc., Usa
D-0660-2024 - Subpotent Drug

This Class II drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on August 30, 2024 for the product Mupirocin. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0660-2024

Reason for Recall
Subpotent Drug
Initiated
08-30-2024
Reported
10-02-2024
Quantity
2,031,480 ointments

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Pharmaceuticals Inc., USA
Product was distributed nationwide within the United States.
Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22.

Batch or Lot Expiration Information

Lot# : 19223615, 19223537, 19223544,19223568, 19223593,19223641, Exp. Date 08/2024; 19224055,19224281, 19224307, 19224321, 19224341, 19224467, Exp. Date 09/2024; 19224525, 19224542, 19224560,19224580, Exp. Date 10/2024; 19224990, 19224998, 19225014, 19225033, 19225293, 19225304, 19225320, 19225349, 19225367, 19225379, 19225401, Exp. Date 11/2024; 19230115, 19230123, 19230132, 19230137, 19230167, 19230170, Exp. Date 12/2024; 19230572, 19230607, 19230614, 19230628, 19230631, Exp. Date 1/2025; 19230874, 19230925,19230941, 19230957, 19230976,19231232, 19231238, 19231282,19231285, Exp. Date 02/2025.

Affected Packages Involved in this Recall